Exercise as medicine for COVID-19: An ACE in the hole?
作者信息
Heffernan Kevin S, Jae Sae Young
机构信息
Department of Exercise Science, Syracuse University, Syracuse, NY, USA.
Department of Sports Sciences, University of Seoul, Seoul, South Korea.
出版信息
Med Hypotheses. 2020 Sep;142:109835. doi: 10.1016/j.mehy.2020.109835. Epub 2020 May 12.
Abstract
摘要
相似文献
1
Exercise as medicine for COVID-19: An ACE in the hole?运动作为治疗新冠肺炎的药物：一张王牌？
Med Hypotheses. 2020 Sep;142:109835. doi: 10.1016/j.mehy.2020.109835. Epub 2020 May 12.
2
Substituting Angiotensin-(1-7) to Prevent Lung Damage in SARS-CoV-2 Infection?用血管紧张素-（1-7）替代以预防新型冠状病毒感染中的肺损伤？
Circulation. 2020 May 26;141(21):1665-1666. doi: 10.1161/CIRCULATIONAHA.120.047297. Epub 2020 Apr 3.
3
COVID-19: Critical Role of Angiotensin 1-7 in ACE2 Modulation.新型冠状病毒肺炎：血管紧张素1-7在血管紧张素转换酶2调节中的关键作用
Ann Acad Med Singap. 2020 Jun;49(6):398-400.
4
Would ACEIs/ARBs be beneficial for COVID-19 patients without hypertension?血管紧张素转换酶抑制剂/血管紧张素Ⅱ受体阻滞剂对无高血压的新冠患者有益吗？
Pharmacol Res. 2020 Sep;159:104959. doi: 10.1016/j.phrs.2020.104959. Epub 2020 Jun 4.
5
The role of ACEIs/ARBs in COVID-19: Friend or foe?血管紧张素转换酶抑制剂/血管紧张素Ⅱ受体阻滞剂在2019冠状病毒病中的作用：是友还是敌？
Med Hypotheses. 2020 Sep;142:109810. doi: 10.1016/j.mehy.2020.109810. Epub 2020 May 5.
6
Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors-lessons from available evidence and insights into COVID-19.冠状病毒与 ACE2、血管紧张素 II 和 RAS 抑制剂的相互作用——来自现有证据的教训和对 COVID-19 的深入了解。
Hypertens Res. 2020 Jul;43(7):648-654. doi: 10.1038/s41440-020-0455-8. Epub 2020 Apr 27.
7
COVID-19 and cardiovascular disease: What we know, what we think we know, and what we need to know.2019冠状病毒病与心血管疾病：我们已知的、我们自认为已知的以及我们需要了解的情况。
J Mol Cell Cardiol. 2020 Jul;144:12-14. doi: 10.1016/j.yjmcc.2020.04.026. Epub 2020 Apr 24.
8
[The RAAS and SARS-CoV-2: A riddle to solve].[肾素-血管紧张素-醛固酮系统与新型冠状病毒2：待解之谜]
Hipertens Riesgo Vasc. 2020 Oct-Dec;37(4):169-175. doi: 10.1016/j.hipert.2020.05.005. Epub 2020 May 27.
9
[Renin-Angiotensin-System (RAS) and COVID-19 - On The Prescription of RAS Blockers].[肾素-血管紧张素系统（RAS）与2019冠状病毒病——关于RAS阻滞剂的处方]
Pneumologie. 2020 Sep;74(9):611-614. doi: 10.1055/a-1165-6994. Epub 2020 Sep 11.
10
Kidney and Lung ACE2 Expression after an ACE Inhibitor or an Ang II Receptor Blocker: Implications for COVID-19.使用血管紧张素转换酶抑制剂或血管紧张素II受体阻滞剂后肾脏和肺部血管紧张素转换酶2的表达：对2019冠状病毒病的影响
J Am Soc Nephrol. 2020 Sep;31(9):1941-1943. doi: 10.1681/ASN.2020050667. Epub 2020 Jul 15.
引用本文的文献
1
Inflammation in COVID-19 and the Effects of Non-Pharmacological Interventions during the Pandemic: A Review.COVID-19 中的炎症与大流行期间非药物干预的影响：综述。
Int J Mol Sci. 2022 Dec 9;23(24):15584. doi: 10.3390/ijms232415584.
2
Physical Activity, Dietary Behavior, and Body Weight Changes during the COVID-19 Nationwide Level 3 Alert in Taiwan: Results of a Taiwanese Online Survey.《台湾 COVID-19 全国第三级警戒期间身体活动、饮食行为和体重变化：一项台湾线上调查结果》
Nutrients. 2022 Nov 21;14(22):4941. doi: 10.3390/nu14224941.
3
Respiratory issues in patients with multiple sclerosis as a risk factor during SARS-CoV-2 infection: a potential role for exercise.多发性硬化症患者在感染 SARS-CoV-2 期间的呼吸问题：运动的潜在作用。
Mol Cell Biochem. 2023 Jul;478(7):1533-1559. doi: 10.1007/s11010-022-04610-1. Epub 2022 Nov 21.
4
Exercise Training in Post-COVID-19 Patients: The Need for a Multifactorial Protocol for a Multifactorial Pathophysiology.新冠疫情后患者的运动训练：针对多因素病理生理学制定多因素方案的必要性
J Clin Med. 2022 Apr 15;11(8):2228. doi: 10.3390/jcm11082228.
5
Angiotensin II Promotes Skeletal Muscle Angiogenesis Induced by Volume-Dependent Aerobic Exercise Training: Effects on miRNAs-27a/b and Oxidant-Antioxidant Balance.血管紧张素II促进容量依赖性有氧运动训练诱导的骨骼肌血管生成：对miRNAs-27a/b及氧化-抗氧化平衡的影响
Antioxidants (Basel). 2022 Mar 28;11(4):651. doi: 10.3390/antiox11040651.
6
Combined Effects of Exercise Training and Nutritional Supplementation in Cancer Patients in the Context of the COVID-19: A Perspective Study.2019年冠状病毒病背景下运动训练与营养补充对癌症患者的联合影响：一项前瞻性研究
Front Nutr. 2022 Mar 9;9:847215. doi: 10.3389/fnut.2022.847215. eCollection 2022.
7
Home-Based Remedies to Prevent COVID-19-Associated Risk of Infection, Admission, Severe Disease, and Death: A Nested Case-Control Study.预防新冠病毒感染、入院、重症及死亡相关风险的家庭疗法：一项巢式病例对照研究
Evid Based Complement Alternat Med. 2022 Mar 16;2022:4559897. doi: 10.1155/2022/4559897. eCollection 2022.
8
Moderate Intensity Aerobic Exercise Potential Favorable Effect Against COVID-19: The Role of Renin-Angiotensin System and Immunomodulatory Effects.中等强度有氧运动对2019冠状病毒病的潜在有益作用：肾素-血管紧张素系统的作用及免疫调节效应
Front Physiol. 2021 Nov 15;12:747200. doi: 10.3389/fphys.2021.747200. eCollection 2021.
9
Women's Lives Matter-The Critical Need for Women to Prioritize Optimal Physical Activity to Reduce COVID-19 Illness Risk and Severity.女性的生命至关重要——女性迫切需要优先考虑最佳身体活动，以降低 COVID-19 患病风险和严重程度。
Int J Environ Res Public Health. 2021 Sep 29;18(19):10271. doi: 10.3390/ijerph181910271.
10
Relationships between inflammatory and metabolic markers, exercise, and body composition in young individuals.年轻个体中炎症和代谢标志物、运动与身体成分之间的关系。
J Clin Transl Res. 2021 May 14;7(3):289-296. eCollection 2021 Jun 26.
本文引用的文献
1
Response by Zhang et al to Letter Regarding Article, "Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19".张等人对关于文章《住院使用血管紧张素转换酶抑制剂和血管紧张素 II 受体阻滞剂与 COVID-19 住院高血压患者死亡率的关联》的信件的回复
Circ Res. 2020 Jun 5;126(12):e142-e143. doi: 10.1161/CIRCRESAHA.120.317242. Epub 2020 Jun 4.
2
Angiotensin-converting enzyme 2 in severe acute respiratory syndrome coronavirus and SARS-CoV-2: A double-edged sword?血管紧张素转换酶 2 在严重急性呼吸综合征冠状病毒和 SARS-CoV-2 中的作用：一把双刃剑？
FASEB J. 2020 May;34(5):6017-6026. doi: 10.1096/fj.202000782. Epub 2020 Apr 19.
3
A tale of two pandemics: How will COVID-19 and global trends in physical inactivity and sedentary behavior affect one another?两场大流行的故事：新冠疫情与缺乏身体活动及久坐行为的全球趋势将如何相互影响？
Prog Cardiovasc Dis. 2021 Jan-Feb;64:108-110. doi: 10.1016/j.pcad.2020.04.005. Epub 2020 Apr 8.
4
Covid-19 infection and mortality: a physiologist's perspective enlightening clinical features and plausible interventional strategies.新型冠状病毒肺炎感染与死亡率：生理学家视角下的临床特征与可行干预策略解析
Am J Physiol Lung Cell Mol Physiol. 2020 May 1;318(5):L1020-L1022. doi: 10.1152/ajplung.00097.2020. Epub 2020 Mar 24.
5
Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics.血管紧张素受体阻滞剂可作为治疗 SARS-CoV-2 的候选药物。
Drug Dev Res. 2020 Aug;81(5):537-540. doi: 10.1002/ddr.21656. Epub 2020 Mar 4.
6
Physical Exercise and ACE2-Angiotensin-(1-7)-Mas Receptor Axis of the Renin Angiotensin System.体育锻炼与肾素血管紧张素系统的ACE2-血管紧张素-（1-7）-Mas受体轴
Protein Pept Lett. 2017 Nov 17;24(9):809-816. doi: 10.2174/0929866524666170728151401.
7
Original Research: ACE2 activator associated with physical exercise potentiates the reduction of pulmonary fibrosis.原创研究：与体育锻炼相关的血管紧张素转换酶2激活剂可增强肺纤维化的减轻效果。
Exp Biol Med (Maywood). 2017 Jan;242(1):8-21. doi: 10.1177/1535370216665174. Epub 2016 Aug 21.
8
Angiotensin converting enzyme 2 abrogates bleomycin-induced lung injury.血管紧张素转换酶 2 可阻断博来霉素诱导的肺损伤。
J Mol Med (Berl). 2012 Jun;90(6):637-47. doi: 10.1007/s00109-012-0859-2. Epub 2012 Jan 14.
Zotero 插件